Compare BZAIW & NOVTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BZAIW | NOVTU |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2021 | 1999 |
| Metric | BZAIW | NOVTU |
|---|---|---|
| Price | $0.11 | $62.21 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 43.4K | 3.1K |
| Earning Date | 05-14-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.43 | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | N/A | ★ $521,290,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $77.55 |
| Revenue Growth | N/A | ★ 35.49 |
| 52 Week Low | $0.09 | $47.57 |
| 52 Week High | $1.50 | $76.95 |
| Indicator | BZAIW | NOVTU |
|---|---|---|
| Relative Strength Index (RSI) | 39.94 | 50.72 |
| Support Level | $0.09 | $59.02 |
| Resistance Level | $0.15 | $64.51 |
| Average True Range (ATR) | 0.01 | 1.83 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 29.66 | 22.73 |
Blaize Holdings Inc provides transformative artificial intelligence (AI)-enabled edge computing solutions comprised of both its proprietary hardware and software, and third-party hardware solutions. Its portfolio includes programmable AI processors in various form factors, which can be deployed across sectors such as smart cities, defense, retail, and enterprise markets. The company operates as a single operating and reportable segment. The majority of the company's revenue is derived from Hardware revenue, which includes the sale of its semiconductor products and/or third-party hardware products that support semiconductor products through various supply agreements. Geographically, it generates the maximum revenue from China.
Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.